Relationship between pre-existing allergies and anaphylactic reactions post mRNA COVID-19 vaccine administration

Two mRNA vaccines for COVID-19, Pfizer-BioNTech and Moderna, are approved for emergency use in the United States. After their approval and dosing in millions of recipients, reports of anaphylaxis began to appear in the Vaccine Adverse Reporting System (VAERS). Here we provide an analysis of the rela...

Descripción completa

Detalles Bibliográficos
Autores principales: Desai, Aditya P., Desai, Aryan P., Loomis, Gregory J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220987/
https://www.ncbi.nlm.nih.gov/pubmed/34215453
http://dx.doi.org/10.1016/j.vaccine.2021.06.058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220987/
https://www.ncbi.nlm.nih.gov/pubmed/34215453
http://dx.doi.org/10.1016/j.vaccine.2021.06.058

Ejemplares similares